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Complications during continuous ambulatory peritoneal dial-
ysis. F. Bammatter, G. Keusch, H. Schffl, M. Koller, and U.
Binswanger. Nephrologische Station, Department für Innere
Medizin, Universitdtsspital, Zurich, Switzerland. Twenty-four
patients aged 26 to 71 yr (mean, 53 yr) suffering from kidney
failure due to diabetes (8), glomerulonephritis (5), interstitial
nephritis (7), or other renal disease (4) were trained during 7 to 51
days (mean, 18 days) for continuous ambulatory peritoneal dial-
ysis (CAPD). Self-treatment could be performed by 18 patients.
Six patients (age, 50 to 69 yr, 2 diabetic retinopathy) needed as-
sistance. The followup during I to 12 months (total patient-
months, 113) revealed 6 deaths (not CAPD-related, 4; mean age,
54 yr). Peritonitis occurred in 18 of 24 patients; repeated attacks
were observed in 11 patients, 3 of whom had to be transferred to
hemodialysis treatment. Of 45 episodes of peritonitis, 31 were
cured during a hospital stay of 2 to 72 days (mean, 13 days), 14
were treated as out-patients. Extensive examination of the dialy-
sate in hospitalized patients revealed positive bacterial cultures
in 16 of 31 patients (gram stain positive, Il; negative, 5). Hypo-
proteinemia occurred in 20 of 24 patients; after 3 months of treat-
ment, the total serum protein was between 5 and 6 g/dI in 12 and
between 4 and 5 g/dI in 8 patients. Detailed studies in 17 patients
demonstrated a peritoneal protein loss of 11.2 6.2 g124 hr. Die-
tary intake amounted to 74.8 21.3 g/day. Both peritoneal loss
and low dietary intake in some patients contributed to the devel-
opment of hypoproteinemia. Conclusion. Peritonitis and hypo-
proteinemia are the predominant complications during CAPD.
Patients not able to perform self-treatment exhibit bad com-
pliance to this treatment mode. The death rate in elderly patients
on CAPD is high.
Familial glomerulopathy with fibrilar transmembranous depos-
its. M. Burgin, F. Reutter, E. Hofmann, L. Matter, F. Gloor,
and J. Briner. institut für Pathologie, Klinik für innere Medizin,
Kantonsspital St. Gal/en; Inst itut für Pathologie, Univer-
sitätsspital Zurich, Switzerland. In three siblings and a first de-
gree cousin, aged 33 to 44 yr, an unusual familiar form of glomer-
ulopathy was observed. All patients showed microhematuria,
two developed a nephrotic syndrome, and two had mild protein-
uria. Hypertension was present in two. In one male, progressive
renal failure developed in the 9th year of folio wup. Renal biopsy
samples obtained in all cases showed an identical diffuse gb-
merular lesion characterized by giant subendothelial, smaller
mesangial and transmembranous deposits, as well as mild diffuse
irregular mesangial proliferation. On electron microscopy, the
deposits were of peculiar fibrillar appearance resembling, but
not typical for, those found in cryoglobulinemia. Immunoflu-
orescence done in two biopsy samples was negative in one and
positive with slight granular parietal reaction for 1gM, IgA, kap-
pa- and lambda-light chains in the other. Immune serologic tests
were negative, and paraproteins or cryoglobulins were absent in
all cases. The etiology of this glomerulopathy is not clear. The
lesions resemble those of cryoglobulinemia or lupus erythema-
tosus, which however were excluded by appropriate tests. To
our knowledge no similar form of familiar glomerulopathy has
been described so far.
856
Renal function in cyanotic congenital heart disease. A. Burlet, J.
P. Guignard, E. Aubert, L. Homsi, M. Payot, and C. Godard.
Service de Pédiatrie, CHUV, Lausanne, and Hópital du Dis-
trict, Monthey, Switzerland. Cyanotic heart disease (CHD) is
characterized by chronic hypoxemia and elevated hematocrit
values. Both could affect renal hemodynamics and function.
Renal clearance studies were performed in 18 children presenting
with CHD before corrective surgery. GFR, measured by inulin
clearance, was normal (115 4.5 mI/mm X 1.73 m2), and ef-
fective renal plasma flow, measured by PAH clearance, was sig-
nificantly depressed (410 25 mI/mm X 1.73 m2). As a result,
filtration fraction was significantly elevated to 29%. A negative
correlation was observed between PAH clearance and hemato-
crit (y 1355 — 17.3X, P <0.02) up to hematoerit values of 60%.
The slope leveled off at higher hematocrit values. Free water
clearance (CMo), measured during hypotonic diuresis, correlated
positively with urine flow. The slope of the curve relating CH2O to
urine flow, both factored by GFR, was similar in CHD and nor-
mal control children (N = 8), thus indicating that sodium reab-
sorption in the distal portion of the nephron was normal in chil-
dren with CHD. Acidification and bicarbonate titration studies
demonstrated a state of renal tubular acidosis, with bicarbonate
wasting. The bicarbonate threshold averaged 19.7 0.6 mmoles/
liter; urine pH decreased to 5.15 + 0.08 after NH4CI loading.
Urinary Pco2 increased significantly above blood Pco2 during al-
kaline diuresis (U-B Pco2, 19.6 mm Hg), thus demonstrating nor-
mal acidification by the distal tubule. We conclude that chronic
hypoxemia and/or elevated hematocrit present in CHD increase
renal vascular resistance and decrease proximal bicarbonate
reabsorption.
Parathyroid-hormone-independent adaptation of tubular phos-
phate transport to renal mass reduction. J. Caverzasio, H. J.
Gloor, H. Fleisch, and J.-P. Bonjour. Pathophysiologisches In-
stitut der Universität Bern, Bern, Switzerland. In man as well as
in experimental animals, progressive renal failure is associated
with a decrease in the fractional reabsorption (FR) of inorganic
phosphate (Pi). This response, which can be considered as an
adaptation phenomenon, has been generally attributed to an in-
crease in parathyroid hormone (PTH) secretion. One report in-
dicates that in chronic thyroparathyroidectomized (TPTX) dogs
treated with large doses of vitamin D, progressive renal failure
can also be associated with a fall in FRPi. However, the con-
comitant administration of vitamin D could account for the ob-
served decrease in FRPi. In the present work, we have investi-
gated whether in the absence of PTH, and without vitamin D
supplementation, chronic reduction in renal mass leads to a de-
crease in the tubular capacity to reabsorb Pi. Male rats weighing
200 g were either TPTX or sham-operated (intact). One week
later, the two groups were either subtotally nephrectomized
(NX) or sham-operated (control). Four weeks later, GFR and Pi
reabsorption were determined by clearance methodology under
acute NaCI and Pi infusion, i.e., at endogenous and increased
plasma Pi concentrations (P1). The maximal P1 reabsorption
(TmPi/ml GF) was taken as an estimate of tubular Pi reabsorptive
capacity. In rats with intact parathyroid glands, GFR was 1.56
0.10 (mean SEM) and 0.54 0.10 mI/mm in control and NX,
respectively, whereas TmPiIml GF was in control 2.24 0.07
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and in NX 1.57 0.18 smoles/ml (P < 0.005). In TPTX rats,
GFR was 1.66 0.27 and 0.62 0.06 mllmin in control and NX,
respectively, whereas TmPiIml GF was in control 3.80 0.20
and in NX 2.95 0.13 smoles/ml (P < 0.005). The significant
decrease in tubular Pi reabsorptive capacity observed in TPTX
after subtotal NX was not related to any significant change in
plasma calcium. Further experiments were made in chronically
TPTX rats with more extensive reduction in renal mass so that
GFR was only 5 to 25% of control. In these TPTX animals, FRP1
measured at endogenous and elevated plasma P1 was always sig-
nificantly lower than in NX than in control. This later fall in tubu-
lar P1 reabsorptive capacity occurred despite a chronic decrease
in plasma calcium, which in itself has been shown to stimulate Pi
reabsorption in TPTX animals. Conclusion. Our study provides
conclusive evidence that a decrease in the tubular capacity to
reabsorb Pi can occur in response to renal mass reduction in ani-
mals deprived of PTH. This PTH-independent response can be
observed in the absence of a chronic elevation in plasma cal-
cium. Thus, these results suggest that PTH is not the essential
mediator for the adaptation of tubular P1 transport to progressive
nephron loss.
Behavior of cefoperazone (a new cephalosporin) in man: Influ-
ence of renal insufficiency. P. Dayer, L. Balant, M. Rudhardt, A.
F. Allaz, and J. Fabre. Policlinique universitaire de médecine,
Genève, Switzerland. Cefoperazone (T-1551) is a cephalosporin
with a spectrum extended toP. aeruginosa and S. marcescens.
Its pharmacokinetics was studied in 8 healthy volunteers
(NORM) and 6 patients with renal insufficiency (RI : creatinine
clearance of 10 to 40 mI/mm). In NORM, serum concentrations
averaged 134 17 g/ml at the end of an i.v. infusion of 2 gin 2
hr; in RI a mean value of 215 g/ml was reached (range, 146 to
268 sg/ml). When these values were normalized with respect to
body weight, the peak levels were 9.65 1.34 g liter1 kg for
NORM, and 10.6 4itg . liter1 . kg for RI. (range, 7.9 to 12). This
correction had no effect on the coefficient of variation (cv) of
NORM peak concentration, but it reduced the cv for RI from 24
to 17%. The half-life of elimination was only slightly prolonged in
RI (2.27 hr; range, 1.3 to 2.9 hr) as compared to NORM (1.66
0.25 hr). In NORM, the amount of cefoperazone eliminated in
the urine during 12 hr was 23.6 3.7% of the dose; urinary ex-
cretion was reduced in RI (from 1.5 to 12%). In NORM, the total
serum clearance amounted to 77.7 15.3 mI/mm (renal Cl, 18.3
1.5 mI/mm; extrarenal Cl: 59.4 14.8 mI/mm). These parame-
ters were reduced in RI (total CI, 45.1 mI/mm; renal Cl, 3.4 ml!
mm; extrarenal Cl, 41.8 mI/mm). These modifications, however,
do not entail major modifications of the kinetic profile of cefo-
perazone. As a consequence, from a pharmacokinetic point of
view, there is no need to modify the dosage regimen of cefopera-
zone in patients with renal insufficiency, contrarily to the other
cephalosporins.
Assessment of kidney transplant function by computer-assisted
isotopic renography. A. Delaloye-Bischof, J. P. Wauters, H. R.
Brunner, and B. Delaloye. Div. aut. de Médecine Nucléaire and
Div. de Nephrologie, Dept de Médecine, Centre Hospitalier
Universitaire, Lausanne, Switzerland. In 36 patients with kidney
transplants, 198 renal studies were performed with the scin-
tillation camera. The tracers used were 1311 or 'I orthoiodo-
hippurate, and occasionally 99mTc compounds. The sequen-
tial images were examined with regard to tracer arrival time and
distribution in the kidney and the urinary tract. Analysis of the
computerized renogram and evaluation of the accumulation in-
dexes (comparison of tracer activity on kidney surface during the
first 30 sec and during the following minute with the injected ac-
tivity) permitted semiquantitative assessment of renal function.
The accumulation index was considerably decreased in case of
rejection (4.64 1 .95) as compared to transplant patients with
obstructive uropathy (7.32 1.53), transplant patients with nor-
mal renal function (9.11 2.03) or normal subjects (11.04
1 .96). The elimination index, defined as the ratio of the tracer
activity 3 mm and 20 mm after injection, was decreased in trans-
plant patients with normal renal function (2.29 0.60) compared
to normal subjects (7.29 2.76). This index decreased further
during rejection (0.74 0.35) as well as during obstructive urop-
athy (0.83 0.40). In 192 studies, the comparison of the scm-
tigraphic diagnosis with the final diagnosis disclosed 17 false-neg-
ative and 24 false-positive results. Although urine leakage was
easily diagnosed on scintiphotographs, the simultaneous evalua-
tion of accumulation and elimination indexes was most useful in
the differential diagnosis between rejection and obstructive uro-
pathy. In our experience, this method represents a practical
approach because it is rapid, noninvasive, and can be applied
at any level of renal junction.
Short treatment of urinary tract infection in children. C. Go-
dard, P. Girardet, R. Hynek, C. Delarue, P. Frutiger, andJ. P.
Christen. French-Swiss Group for Studies in Ambulatory Pediat-
rics, Lausanne, Switzerland. The duration of treatment for acute
urinary tract infection (UTI) in children is controversial. Usually
an antimicrobial agent is given for a period of 7 to 10 days. We
have studied prospectively the efficacity of shorter therapy. In 69
children aged I month to 14 yr (60 girls, 9 boys), 79 episodes of
uncomplicated UTI were treated by co-trimoxazole (5 to 6 mg
TMP/kg/day) administered for 3 days. Patients with urinary tract
malformation, renal scarring, and/or renal insufficiency were ex-
cluded from the study. Results. (I) Urine culture performed on
the 8th day after treatment was negative in all but one case. (2)
Followup (6 to 24 months). UTI recurred in 30 cases or 37.9% (18
of 48 lower UTI, 2 of 11 upper UTI, 4 of 10 UTI of uncertain site
and 6 of 10 asymptomatic bacteriuria). Recurrences were more
frequent after a second (14 of 25, or 56%) than after a first UTI
(16 of 54, or 29.6%), and were reinfections with new organisms in
most instances. (3) The recurrence rate did not differ significant-
ly from that of a group of 20 UTI (first episode) treated with co-
trimoxazole for 7 to 10 days (6 of 20, or 30%). Conclusion. Anti-
microbial therapy for 3 days is as effective as more prolonged
therapy in eradicating uncomplicated UTI in infants and chil-
dren. Even shorter courses are being investigated.
Dermatologic complications after kidney allotransplantation. J.
L. lEplattenier, U. Binswanger, F. Ott, F. Largiadèr. Neph-
rologische Station, Departement für Innere Medizin; Derma-
tologische Klinik; Chirurgische Klinik A, Universitätsspital,
Zurich, Switzerland. Two hundred five kidney allograft recipi-
ents were studied either during a routine control visit (N 91) or
by screening of the medical records (N = 114) for dermatologic
problems. The following findings were listed according to the se-
verity and the degree of disturbance caused in patients:
N %
Neoplasia
Benign 6 2.9
Basalioma 3 1.4
Spinalioma 4 1.9
Precancerosis 4 1.9
Pyodermia
Folliculitis 5 2.4
Abscess 3 1.4
Viral infection
Warts 43 20.9
Condylomata 5 2.4
Herpes simplex zoster 26
15
12.7
7.3
Loss of hair 55 26.8
Mycosis
Candida (mouth) 60 29.2
Pityriasis 12 5.9
Cushingoid syndrome
Facies lunaris 86 41.9
Rubeosis 24 11.7
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Not including the initial phase after allotranspiantation, 75% of
the patients studied suffered from skin problems, one third ex-
hibiting two or more lesions. Steroid-related changes were pre-
dominant. Skin cancers were diagnosed at a mean of 6.2 yr after
kidney grafting. According to these data, regular dermatologic
surveillance is recommended after kidney allotransplantation.
Redistribution of intrarenai blood flow after carotid artery oc-
clusion in the rat: Significance of changes in perfusion pressure,
renal nerves, and prostaglandin activity. A. Gilg, W. Ziegler, and
B. Truniger. Medizinische Kliniken, Kantonsspital Luzern and
University Hospital Zurich, Switzerland. On the basis of micro-
sphere distribution studies in the rat, acute bilateral carotid ar-
tery occlusion (CAO) was found to cause a small but significant
increase in outer cortical flow fraction (OC/C) (QCAO = OCIC,01/
OC/CCAO = 0.968 (SD) 0.03, N = 10), as compared with a Q =
0.998, n = 10) resulting from reproducibility studies). In order to
define the mechanisms responsible for this redistribution, experi-
ments were performed a) with interrenal aortic constriction (AC)
keeping the perfusion pressure of the left kidney constant, b) in
unilaterally denervated kidneys, c) in animals pretreated with
prostagiandin inhibitors (indomethacin and Ro 20-5720). When
renal perfusion pressure was kept constant, no redistribution oc-
curred upon CAO (QAC = 0.987 (SD) 0.030, N = 8). In dener-
vated kidneys, the redistribution induced by CAO did not differ
from that observed in contralateral control kidneys (QDEN =
0.959 (SD) 0,030, N = 7). Animals pretreated with prostaglan-
din inhibitors (P01) showed a significant redistribution in the
'unprotected" right kidney (QPGI = 0.942 (SD) 0.054, N = 13)
and a similar increase in outer cortical flow fraction in the normo-
tensive kidney (Qpct+ AC = 0.967 (SD) 0.029, N 13). It is
concluded (F) that the increase in OC/C induced by CAO in the
rat is mainly due to an increase in perfusion pressure; (2) that the
redistribution is independent of sympathetic vasoconstrictor
stimuli which seem to be counterbalanced by prostaglandin ac-
tivity, and (3) that changes in prostanglandin activity are not re-
sponsible for the pressure induced redistribution of cortical
blood flow after CAO.
Hyperprolactinemia in chronic hemodialysis. F. Gómez, R. de
Ia Cueva, J. P. Wauters, and T. Lemarchand-Béraud.
Département de Médecine, C.H.U.V., Lausanne, Switzerland,
and Residencia "General Sanjurjo," Valencia, Spain. Elevated
plasma prolactin (PRL) was found in 31 of 56 patients undergoing
chronic hemodialysis (CHD) for terminal renal failure. Spontane-
ous hyperprolactinemia was more frequent in women (11 of 15)
than in men (7 of 28), and the mean values of PRL were also
higher in women (52 14 ng/ml, N = 15, vs. 15 2 ng/ml, N =
28, mean SEM, P < 0.001). All patients of both sexes on
methyldopa treatment (N = 13) presented very high PRL levels
(30 to 1107 ng/ml). The response of PRL to stimulant or suppres-
sive agents suggested that prolonged plasma half-life played a
role in the elevation of basal PRL levels. Immunoactive PRL
appeared to be biologically active, because several amenorrheic,
hyperprolactinemic women showed galactorrhea. Moreover,
correction of PRL levels during a short (6 weeks) treatment with
the dopaminergic drug bromocriptine resulted in a rise of basal
gonadotropins and in the recurrence of menses in several wom-
en. Men with hyperprolactinemia presented decreased libido
and/or impotence despite normal or low-normal testosterone lev-
els; bromocriptine treatment also resulted in a rise of basal go-
nadotropins, but a longer trial may be necessary for a clinical
improvement to be observed in men. Four of the patients on
methyldopa, who presented huge PRL levels also presented to-
mographic changes of the sella turcica, which were consistent
with apituitary swelling. CHD patients are prone to have clinical-
ly significant hyperprolactinemia that may impair their sexual
function. Treatment with dopamine agonists can normalize PRL
levels, and it is conceivable that, in the long run, symptoms such
as decreased libido, impotence, and amenorrhea could be re-
lieved with subsequent psychologic benefit. Drugs that enhance
PRL secretion should be used with great care in this context.
Duration of treatment in sequential ultrafiltration and hemo-
dialysis. J. Iseli and K. Záruba. Nierenstation Stadispital Waid
Zurich, Switzerland. A combined treatment with the sequential
ultrafiltration (SUF) and subsequent conventional hemodialysis
(HD) was applied four times to six hemodialysis patients. With
this treatment, before the SUF, after the SUF, and after the HD,
measurements were made, in both blood and ultrafiltrate, of
BUN, creatinine, sodium, potassium, inorganic phosphate and
total protein. The results show that SUF does not change the
measured values substantially. To guarantee an adequate com-
bined SUF-HD, the total length of treatment has to be prolonged
by the time of SUF.
Idiopathic hypercalciuria: Evaluation of the diagnostic ap-
proach. P. Jaeger and P. Burckhardt. Dept. of Medicine, Uni-
versity Hospital, Lausanne, Switzerland. The generally admitted
classification for IHC is often difficult to apply in a single case,
due to the overlap of the various groups. To classify our own
patients with IHC, we designed an outpatient protocol. 24-hr
urine and fasting blood samples were obtained under three dif-
ferent conditions: (a) regular diet; (b) 'no milk products" diet for
5 days; (c) regular diet supplemented for 3 days with Ca (i.e., +3
glday calcium); in addition, (d) under regular diet, fasting 2-hr
urine was collected. Blood was analyzed for Ca, P04, creatinine,
protein, and PTH, and urine for Ca, P04, and creatinine. The
results obtained in 32 healthy volunteers were used to define the
normal values. Thirty-six patients with recurrent urolithiasis and
IHC were included in the protocol: when compared to the con-
trols, they fell into the following groups: (A) Renal hypercalciuria
(31 cases) as defined, after low-Ca diet, by an elevated UCaV in
the 24-hr urine, or, in borderline cases, by a lowered "TRCa"
(i.e., calculated with total blood Ca). It can be subdivided into (I)
a type with hyperabsorption (10 cases) as defined by an exagger-
ated increase of UCaV in the 24-hr urine after Ca load; (2) a type
without hyperabsorption (21 cases). (B) Absorptive hyper-
calciuria (5 cases) as defined by a normal UcaV in the 24-hr urine
after a low-Ca diet and an exaggerated increase of UcaV in the 24
hr urine after a Ca load. A low-TRP was found in 6 cases, all of
them being in the "renal" group. In 3 cases, fasting urinary Ca
was elevated, as in renal IHC, but returned to normal after 5
days of low-Ca diet. In addition, Ca supplement at dinner in nor-
mal subjects was found to increase the fasting urinary Ca of the
following morning. In none of the cases was PTH elevated. In
addition, plasma PTH and Ca were measured in 171 patients with
urolithiasis: elevated PTH in a normocalcemic patient was found
only once. Conclusions. (I) This outpatient protocol is an easy
and useful tool for classifying IHC patients. (2) For the diagnosis
of renal IHC, measurement of urinary Ca is more reliable in the
24-hr urine after a low-Ca diet than in fasting urine. (3) The pos-
tulated secondary hyperparathyroidism in renal IHC could not
be confinned.
Transplant pyelonephritis. V. Kym, U. Binswanger, J. Briner,
and F. Largiader, Departement fur Innere Medizin, Institut für
Pathologie, Chirurgische Klinik A, Universitdtsspital, Zurich,
Switzerland. Examination of the urine in 216 kidney allograft re-
cipients showed significant bacteriuria in 274 samples out of 1802
urine samples tested. Bacteriuria was found in 30 patients with
recurrent or chronic persistent infections of the urinary tract;
this patient group was studied by examination of 399 urine sam-
ples (mean 13.3 samples/patient). Four patients suffered from
urologic complications after kidney grafting and were excluded
from the study; 15 patients were diagnosed clinically and/or his-
tologically with transplant pyelonephritis, II patients with cys-
titis. Of main importance for the diagnosis of transplant pyelone-
phritis were findings of persistent leucocyturia and the presence
of antibody-coated bacteria. Both of these findings were repeat-
edly seen in all patients with transplant pyelonephritis. Clinical
symptoms included fever and dysuria. In contrast to patients suf-
fering from cystitis, transplant function deteriorated in 13 out of
15 patients with transplant pyelonephritis; 2 patients had to be
treated by hemodialysis. Septicemia occurred in 8 of the 15 pa-
tients studied. The data illustrate the frequency of transplant py-
elonephntis, observed in 15 out of 26 patients with chronic uri-
nary tract infection after kidney allograft transplantation. As a
predisposing factor, obstruction of the urinary tract was diag-
nosed in 8 of the 15 patients at the time transplant infection was
diagnosed. Successful antibiotic treatment resulted in stable
transplant function in 3 patients; 4 patients exhibited even lower
serum creatinine levels after therapy.
Plasma catecholamines, renin, and hemodynamics in acute hy-
percalcemic hypertension in man. C. Marone, C. Beretta-Piccoli,
and P. Weidmann. Medizinische Universitdts-Poliklinik, Bern,
Switzerland. Hypercalcemia may cause hypertension, especially
in association with reduced renal function. The mechanism of
hypercalcemic hypertension is still largely unclear. Therefore,
the effect of acute hypercalcemia on blood pressure (BP), blood
volume, systemic hemodynamics (by the Fick method using oxy-
gen saturation), plasma catecholaniines (by radioenzymatic as-
say), renin (PRA), and aldosterone (by radioimmunoassay) was
investigated. After 1 hr of equilibration, 6 patients with normal or
mildly elevated BP and serum creatinine levels ranging from 1.2
to 2.5 mg/dl received an iv. infusion of calcium (Ca) gluconate in
5% glucose, delivering 15 mg of Ca/kg of body wt over 3 hr.
Measurements were performed before and after 2 and 3 hr of
infusion. Ca-infusion increased mean serum Ca from 8.8 to 13.2
mg/dl, systolic BP from 147 15 to 185 (saM) 18 mm Hg (P <
0.01), and diastolic BP from 84 4 to 97 5 mm Hg (P < 0.05).
Blood and plasma volumes were decreased by 6 and 9%, respec-
tively (P < 0.05 and 0.01); heart rate and cardiac output re-
mained unchanged, and total peripheral resistance was increased
from 1826 246 to 2424 463 dynes sec/cm5. Plasma epineph-
rifle was increased from 4.0 1.0 to 6.0 1.4 ngfdl (P < 0.05),
PRA was decreased from 2.2 0.6 to 1.6 0.5 ng/ml/hr (P <
0.05). Plasma aldosterone, norepinephrine, and dopamine re-
mained unaltered. These findings demonstrate that acute hyper-
calcemic hypertension is mediated by an increase in peripheral
vascular resistance. The pressor effect of Ca is apparently not
associated with increased adrenergic nervous activity or renin-
aldosterone activation, but may be partly counteracted by a de-
crease in PRA and plasma volume. Hypercalcemic hypertension
may be induced by a direct effect of Ca on blood vessels, and a
calcium-mediated increase in epinephrine release from the adre-
nal medulla may be a contributory factor.
Effects of acute metabolic acidosis and alkalosis on renal magne-
sium transport. C. C. Marone and R. A. L. Sutton. Department
of Medicine, University of British Columbia, Vancouver, Cana-
da. The effects of metabolic acidosis and alkalosis on renal mag-
nesium transport have not been defined well. We have examined
renal magnesium handling in three groups of 10 acutely thyro-
parathyroidectomized rats infused with isotonic NaCI (controls),
NH4CI (acidosis) and NaHCO3 (alkalosis), respectively. To ex-
amine the interactions of furosemide with metabolic acidosis and
alkalosis, we studied the rats in a second phase during which a
maximal dose of the drug was added to their respective in-
fusions. Before furosemide, blood pH was 7.40 in controls, 7.27
(P < 0.001) in acidosis and 7.56 (P < 0.001) in alkalosis. Filtered
magnesium load was not significantly different in the three
groups, but fractional excretion of magnesium (FEMg) was 33.7,
37.4 and 13.3% respectively. Following furosemide, blood pH
was unchanged in each group, but FEMa increased significantly to
55.4, 71.1 (P < 0.01, compared with controls) and 41.4% (P <
0.01, compared with controls) respectively. These data indicate
that metabolic alkalosis per se enhances renal magnesium trans-
port and that alkalosis diminishes the magnesiuric effect of fu-
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rosemide. Acidosis per se does not significantly alter magnesium
transport, but the magnesiunc effect of furosemide is significant-
ly increased. These interactions suggest that metabolic acid-base
changes and furosemide influence magnesium reabsorption at
different tubule sites.
The fibroblast model: A possible way of studying arachidonic
acid metabolism in hypertension. F. Mestel and 0. Oetliker. Pros-
taglandinlabor, Abteilung fur Paediatrische Nephrologie, Uni-
versitäts-Kinderklinik Bern, Berne, Switzerland. Cell cultures in
general, are well-defined models for studying metabolism. Ge-
netic aspects, as well as exogenous influences, can be examined.
Since AA-metabolites are involved in blood pressure regulation,
cultured cells might be used to investigate the producton of Va-
soactive prostaglandins (PGs), such as prostacyclin (P12) and
PGE2. In contrast to other, less accessible cell lines, on which
most of the P1 studies are done, fibroblasts offer the possibility to
work with material from patients. '4C-AA labeling of cells and
subsequent stimulation allows the detection of AA metabolites
on thin-layer chromatography (TLC). Fibroblasts show rather
small amounts of 6-keto PGF1, the degradation product of P12,
whereas in the platelet bioassay P12-like activity is well-detect-
able. In the present study, we tried to improve the visualisation
of AA-metabolites on TLC. Therefore we compared the produc-
tion of 6-keto PGF1. and PGE2 after bradykinin-stimulated re-
lease into medium containing albumin (pH, 7.8) and into buffered
medium at pH 7.8 and 4.8 without albumin: In human, as well as
in rat fibroblasts, the detectability of 6-keto PGF1, was not dif-
ferent when released into medium at pH 7.8 with or without albu-
min, though some more PGE2 was detected in albumin-free me-
dium. Release into protein free medium at pH 4.8 increased 6-
keto PGF1, 4.2-fold (P < 0.001) and PGE3 2.1-fold (P < 0.025),
compared to pH 7.8. With this model we studied the PG-pattern
of 3 normotensive children. A comparison of spontaneously hy-
pertensive rats (SHR) with corresponding controls in 7 respec-
tive cultures showed significantly higher P12 (P = 0.005) in con-
trols than in SHR. PGE2, however, was not significantly dif-
ferent. Conclusions: (1) Human and rat fibroblasts in culture
produce P12. (2) Vasoactive PGs are better visualized in albumin
free medium at low pH values. (3) The well-accessible fibroblast
model is a way to observe AA metabolism of individual patients
and of experimental animals. (4) SHR produce less P12 than con-
trols.
Capillaroaclerosis of the urinary tract. The pathognomonic find-
ing of analgesic (phenacetin) abuse. M. 3. Mihatsch, F. Gloor, 3.
Torhorst, H. 0. Hofer, and H. U. Zollinger. Institute of Patholo-
gy Basle and St. Gall, Switzerland. Capillarosclerosis (C) is
pathognomonic for phenacetin abuse. There were no false-posi-
tive cases in a series of a 100 clinically controlled cases of C. C is
not found in cases of diabetes mellitus, hypertension, kidney
transplants, other diverse kidney affections, or in senility. C is
present in roughly 80% of clinically documented cases of phe-
nacetin abuse. This permits the identification of clinically un-
known cases of phenacetin abuse and is thereby an ideal parame-
ter for an epidemiologic study. C is present only in the vessels
directly beneath the epithelium of the urinary tract. C is charac-
terized by strong PAS- and Sudan-positive thickening of the cap-
illary basement membrane. The lipid in the thickened capillary
basement membrane is brown in unstained sections and gives a
positive reaction in polarized light. The brown color of the mu-
cosa of the urinary tract is always associated with C. The re-
verse, however, is not the rule. Electron microscopy shows the
thickening of the basement membrane to be composed of thin
lamellae in a concentric arrangement between which there are
masses of lipid vacuoles and cellular debris. The incidence of C
in the various regions of the urinary tract is as follows: pelvis of
the kidney, 88%; upper 2/3 of the ureter, 88%; urinary bladder (in
the vicinity of the ureteral orifices), 19%.
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Reduced renal response to phosphate restriction in X-linked
hypophosphatemic mouse. R. C. Mühlbauer, J.-P. Bonjour and
H. Fleisch. Pathophysiologisches Inst itut der Universität Berne,
Bern, Switzerland. Previous studies in several animal species
such as rat, pig, and mouse have demonstrated that the renal
tubule has the ability to enhance its reabsorptive transport ca-
pacity for inorganic phosphate (Pi) in response to Pi deprivation.
In the present work, we have investigated whether in response to
a Pi restriction the overall tubular Pi reabsorptive capacity of X-
linked hypophosphatemic (hyp) mice increases to the same ex-
tent as that of control littermates. Male hyp mice and control
litterrnates were pair-fed for 10 to 20 days with either a high Pi
diet (HPD: 0.77% phosphorus) or a low Pi diet (LPD: 0.25%
phosphorus). After this period, animals were anesthetized, and
clearance studies were made. Net tubular Pi reabsorption was
measured at various plasma Pi concentrations under NaCI and
increasing Pi infusion. The tubular Pi reabsorptive capacity was
estimated by determining the maximal Pi reabsorption (TmPi). In
agreement with previously reported data, the results indicate
that hyp mice have a lower TmPi than control littermates. With
regard to the adaptation to Pi restriction, the following results
were obtained: in control mice, TmPi (mean 5EM) was 2.00
0.17 (N = 14) and 3.59 0.10 tmoles/ml GF (N = 22) (P <
0.001) on HPD and LPD, respectively. In hyp mice, TmPi was
1.19 0.l0(N = 13) and 1.59 0.09 rmoles/ml GF(N =29)on
HPD and LPD, respectively (P < 0.02). Thus, the tubular re-
sponse to LPD appears to be markedly attenuated in hyp mice as
compared to control littermates. This finding indicates that the
complete disappearance of Pi from urine of hyp mice fed LPD
that we have observed at endogenous plasma Pi concentration
results mainly from the decrease in the filtered load of Pi. Further
experiments also indicate that treatment with l,25(OH)2 vitamin
D3 (6, 12, and 24 pmoles/day i.p.) failed to increase significantly
TmPi in hyp mice fed LPD. Conclusion. In hyp mice, there is a
marked reduction in the overall tubular Pi adaptive response to
LPD. The question arises whether this reduced adaptation repre-
sents a primary defect or a secondary event consecutive to the
impaired bone mineralization that characterizes the X-linked
hypophosphatemic condition.
Effect of tolazoline on renal function. S. Naujoks and J. P.
Guignard. Service de Pédiatrie, CHUV, Lausanne, Switzerland.
Tolazoline, an alpha-adrenergic blocking agent with histamine-
like properties, has been used as a pulmonary vasodilator in se-
verely hypoxemic newborn infants. Side effects, such as oliguria
and transient renal failure, were possibly related to the drug. The
effect of tolazoline on renal hemodynamics and function was
studied in normal rabbits. The animals were anesthetized with
pentobarbital and mechanically ventilated with a gas mixture
containing 20% 02 ÷ 4% CO2. lnulin and PAH were used as
markers of GFR and effective renal plasma flow (ERPF), respec-
tively. Blood pressure was recorded throughout the experiment.
Tolazoline, administered at a dose of 1 mg/kg prime and I mg/kg
mm, induced a transient increase in blood pressure from 110 4
to 134 4 mm Hg (P < 0.01). This could be due to increased
cardiac output by direct stimulation of the heart and/or to in-
creased peripheral resistance. GFR and ERPF decreased signifi-
cantly after tolazoline from 1.92 0.27 to 0.96 0.31 and from
10.3 2.0 to 3.3 1.1 mI/kg ' mm (P < 0.01), respectively.
There was also a significant decrease in urine flow from 166 21
to 39 9 1/kg mm (P < 0.01), in sodium excretion from 17.0
3.7 to 2.3 0.6 jsmoleslkg mm (P < 0.01), as well as in potas-
sium and chloride excretion. These changes were associated
with a sharp increase in renal vascular resistance from 10.7 2.0
to 40.9 10.8 mm Hg/mllkg mm (P < 0.001). The effect of
tolazoline was more pronounced when larger doses of the drug
were used. A similar increase in renal vascular resistance was
induced by tolazoline in hypoxemic animals. The large increase
in renal vascular resistance induced by tolazoline is best ex-
plained by a partial alpha-agonist action of tolazoline on renal
vascular smooth muscle. Whether tolazoline retains such alpha-
agonist properties in human hypoxemic neonates remains to be
demonstrated.
Protein loss in continuous ambulatory peritoneal dialysis. M.
Oliveri, and K. Záruba. Nierenstation Stadtspital Waid Zurich,
Switzerland. In peritoneal dialysis, in contrast to hemodialysis,
there is a loss of serum protein in the dialysate. A chronic loss of
protein in the continuous ambulatory peritoneal dialysis (CAPD)
patient could lead to a moderate to severe hypoproteinemia. In 6
CAPD patients the protein concentration in the dialysate was
measured. Protein loss averaged 8.9 g124 hr (range, 5 to 20 g124
hr). In peritonitis, the loss of protein was much higher, up to 60g/
24 hr. To reduce the risk of a chronic hypoproteinemia in pa-
tients who have a large loss of protein in their dialysate, a protein
concentrate can successfully be given orally, in addition to the
protein-rich diet. In patients with peritonitis, a decline in serum
protein may be corrected rapidly with infusion of human albumin
over a short period.
Effect of acute renal artery constriction of renal renin in the rat.
L. Peters-Haefeli, P. Luthi, andf. Atkinson. Institut de Pharma-
cologie de I' Université, Lausanne, Switzerland. We have pre-
viously reported that 6-hr constriction (clip, 0.2 mm I.D.) of the
remaining renal artery of rats uninephrectomized 24-hr pre-
viously, reduced kidney renin concentration by one half (paired
comparison within same rat, i.e., 6-hr clipped kidney vs. kidney
removed 24-hr before clipping). As (I) other stimuli, e.g. hemor-
rhage, which produce acute release of large amounts of renin, do
not produce detectable falls in renal renin concentration, and (2)
30-hr uninephrectomy induces compensatory hypertrophy, we
have examined whether the observed fall in renal renin concen-
tration (RRC) was real or apparent (due to dilution of an un-
changed total renin activity by retention of water, synthesis of
nonrenin proteins, etc.). Sixty-four clipped rats showed a 56
5% fall in RRC from 2757 224 to 1282 151 ng Al 'mg ,hrx7.
Controls (24-hr uninephrectomy followed by sham operation on
remaining renal artery) showed no change in RRC. The weight of
the remaining kidneys 24-hr after uninephrectomy and 6-hr after
clipping had increased by + 59 6% (hypertrophy). Thus, esti-
mated total kidney renin (RRC X weight) fell by 29 4%, and
this was paralleled by a 32 6% fall in kidney protein content
from 850 40 to 560 63, mglg wet wt. However, the fall in
RRC observed was not entirely due to a dilution of total kidney
protein content. Clipping did induce a true fall of about 25% in
renin 'specific activity" (expressed as total kidney renin/kidney
protein content) from 34 3 to 25 2 g Al mg protein-1 (P <
0.05). Only a small percentage of this loss of renin could be ac-
counted for by the amount of renin released into plasma during
the 6 hr following clipping.
Transport of urate and para-aminohippurate in isolated, non-
perfused proximal renal tubules of the pig kidney. C. Schdli, and
F. Roch-Ramel. Institut de Pharmacologie de l'Université, Lau-
sanne, Switzerland. Segments of proximal convoluted (PCT) and
proximal straight (PST) renal tubules of pigs were dissected and
incubated in an oxygenated Ringer's solution containing 1% bo-
vine serum albumin, '4C-urate or 3H-para-aminohippurate (PAH)
at pH 7.4 and at 37 C. After 30 mm, the tubules were rinsed, and
digested in 0.75 N nitric acid. The radioactivity (liquid scintilla-
tion spectrophotometry) of the samples was expressed as
counts per nanoliter of tubular water (calculated from micro-
photographic tubular volume, and tissue water content), or as
counts per nanoliter of incubation medium. Uptake of labeled
compounds into tubular cells was expressed by the tissue water/
medium ratio (TIM). Urate and PAH were accumulated to a
much greater extent in PCT than in PST. Addition of cold urate(l0 M) to 3H-PAH, or cold PAH to 14C-urate, significantly de-
pressed the T/M ratios for the labeled compounds in PCT. The
data suggest that there is a common transport system for urate
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and for PAH in the pig kidney. In this species, the main site of
this transport system is the PCT, whereas in the rabbit this trans-
port system is located mainly in the upper portion of the straight
proximal tubule. Values in the table represent the means 5EM;
N denotes number of tubules and parentheses enclose number of
animals.
+ PAH + urate
(1O—3M) (IO3M)
'4C-urate T/M as 3H-PAH T/M as
(9.105M) % of control (3.l05M) % of control
(T/M) (1 St column) T/M (3rd column)
PCT 5.3 0.5 45.0 10.5 55.8 9.8 24.0 5.8*
N=20(7) N=6(2) N= 15(5) N=8(2)
PST 2.1 0.2 2.9 0.7
N= 17(7) N= 10(5)
*p < 0.005.
1 ,25-Dihydroxycholecalciferol treatment of uremic rats after
high magnesium feeding. H. Schifil, M. Huggler, C. Becker, U.
Binswanger. Nephrologische Station, Departement fur Innere
Medizin, Universitätsspital, Zurich, Switzerland. The hyper-
calcemic response to 1,25-dihydroxycholecalciferol (1,25-
DHCC) treatment was studied in mild uremic rats (5/6 nephrecto-
my) under conditions of varying magnesium (Mg) intake (0.05%
for control and 0.75% for experimental). After 3 weeks of ex-
posure to the high-magnesium diet, a loss of the hypercalcemic
effect of 1,25-DHCC (40 pmoles i.p. during 5 days) was ob-
served. By use of standard clearance experiments, a similarity of
the renal Mg and calcium (Ca) handling could be demonstrated.
At high serum magnesium levels, the fraction of filtered Mg ex-
creted in the urine rose, concomitant with an increased fractional
excretion of Ca (r = 0.81). The bone Mg content was correlated
with serum levels and therefore increased after high dietary
magnesium. Treatment with I ,25-DHCC resulted in an increase
of the bone Ca content (P < 0.05) after low-Mg diet, but not
after high-Mg feeding. It is concluded that high urinary Ca ex-
cretion after Mg loading contributes to the imparied calcemic
response of l,25-DHCC in azotemic rats, while Ca uptake of
bone is impaired.
Does captopril lower blood pressure by an angiotensin-inde-
pendent mechanism? S. C. Textor, H. R. Brunner, and H. Gay-
ras. Centre Hospitalier Universitaire Vaudois, Lausanne, Switz-
erland. The interpretation of results obtained with angiotensin-
converting enzyme (ACE) inhibition has been obscured by the
possible effects of bradykinin accumulation and/or other un-
known nonangiotensin-mediated actions of the drug, We have
studied the effects of captopril (SQ), 100 mg/kg, versus 5% dex-
trose (D5W) given twice daily by gavage to conscious rats receiv-
ing continuous infusions of angiotensin II (All) for 9 days. The
action of SQ on vasodepressor sensitivity to bradykinin (BK)
was measured by establishing dose-response curves to intra-
venous BK. On the final day, the effect of All was assessed by
saralasin (SAR) infusion. Water intake, sodium and potassium ex-
cretion were measured by metabolic studies. As expected,
chronic All produced mean blood pressure (MAP) elevation
greater than that obtained with acute All infusion, escape from
reflex bradycardia, and suppression of endogenous plasma renin
activity (PRA). Comparison of treatments during chronic All:
Dextrose(N=1I) SQ 14,225(N=l0) P
MAP, mm Hg 147 3 145 6
Heart rate,
beats/mm 485 14 482 20
PRA,ng/ml/hr 1.5 6 2.8 1.7
AMAP after SAR,
mmHg —44 5 —43 7
BK sensitivity:
Dose (—30 mmHg),
pg/kg 1.21 0.21 0.10 0.001 <0.001
ACE,
nmoles/min/ml 176 16 32 7 <0.001
Metabolic studies revealed in both groups increased excretion of
sodium and potassium for 5 days after beginning All, which was,
however, delayed during the first day in the SQ group (P <
0.005). Conclusion. In spite of a 10-fold increase in sensitivity to
bradykinin and a documented drop in ACE following captopril
administration, there is no detectable longterm effect on blood
pressure, heart rate, water, sodium or potassium metabolism
during All infusion.
Short-term change in tubular phosphate reabsorption: Effect of
overnight fasting dissociated from phosphate restriction. U.
Tröhler, J.-P. Bonjour, and H. Fleisch. Pathophysiologisches
Institut der Universität Bern, Bern, Switzerland. It is known that
tubular reabsorption of inorganic phosphate (Pi) plays a major
part in the regulation of Pi homeostasis. Its transport capacity
varies according to the supply and requirement of Pi, and this
variation has been observed within 3 days. It can be considered
as an adaptation to the Pi need of the organism. To further sub-
stantiate this concept and to describe more precisely the time
needed for the adaptation to occur, we examined whether the Pi
Groups N
C1
d/min'i00g
Sca
mg/dl
SMg
mg/dl
FEca X 100
%
FEMg X 100
%
Group 1: Nx, Mg 0.05% 6 242.9 56.4 8.85 0.55 1.30 0.10 0.73 0.34 6.88 2.45
Group2:Nx,MgO.05% 4 240.9 42.7 10.96 0.19° 1.94 0.37 1.56 0.73 10.89 1.98
+ 1.25 DHCC
Group 3: Nx, Mg 0.75% 5 308.65 78.0 8.14 0.30 3.88 0.40 5.62 2.l3 31.40 6.70
Group4:Nx,MgO.75% 5 285.88 72.36 9.20 0.46 4.23 0.l9** 10.59 1.89* 45.72 5,55**
+ 1.25 DHCC
Statistical analysis: Group 2 vs. group 1 °P < 0.025; group 3 vs. group I < 0.05 < 0.005; group 4 vs. group 2 * < 0.01 ** <
0.0025.
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reabsorptive capacity vanes with short-term changes in Pi sup-
ply. We also studied if it varies with a short-term variation of a Pi
requirement, which can be expected to occur during fasting. Us-
ing clearance methodology we studied the influence of overnight
fasting on the tubular capacity to reabsorb Pi in rats. Fasted ani-
mals were or were not supplemented with Pi in amounts corre-
sponding to those absorbed by the fed group. This protocol al-
lowed us to dissociate the effect of overnight fasting per se from
that of overnight Pi deprivation. Tubular Pi reabsorptive capac-
ity was found to be lower in overnight fasted animals receiving a
Pi supplement in the drinking water than in fed animals. In over-
night fasting rats it was lower in animals receiving a Pi supple-
ment in the drinking water than in those without Pi supplement.
There was no difference in tubular Pi reabsorptive capacity be-
tween completely fasted and fed rats. These results indicate that
overnight fasting with constant Pi supply decreases the tubular
reabsorptive capacity for Pi, whereas overnight Pi deprivation
stimulates it. These two opposite effects explain the fact that
overnight fasting without Pi supplement has no significant influ-
ence on tubular Pi transport capacity. Furthermore, these results
show that the kidney can adapt its transport capacity for Pi ac-
cording to short-term changes in Pi supply and requirement, that
is in less than 14 hours.
Double-blind comparison of three antihypertensive drugs by in.
ternists in private practice. B. Waeber, H. R. Brunner, R. K. Fer-
guson, G. A. Turini, H. Gavras. Centre Hospital ier Universitaire
Vaudois, Lausanne, Switzerland. The antihypertensive effects of
debrisoquine, methyldopa, and propranolol were studied in a
double-blind fashion by 14 internists in practice. An open phase
of 6 weeks during which treatment consisted only of a diuretic
(mefruside, 25 mg/day), was followed by four treatment periods
of 4 weeks each in randomized sequence consisting of placebo,
debrisoquine (20 mg/day), methyldopa (1000 mg/day), or pro-
pranolol (160 mg/day). Mefruside was continued at the same
dose. At the end of the open phase, the blood pressure of 48
patients with essential hypertension remained elevated at 168/
Ill 20/14 mm Hg (mean SD). A significant fall in blood pres-
sure was achieved not only at the end of active treatments but
also after administration of placebo with the blood pressure
reaching 160/103 20/11 mm Hg. Compared with placebo, blood
pressure was significantly lower during the active medication pe-
riods. However, the comparative fall for systolic blood pressure
ranged only from 6 (debrisoquine) to 12 (methyldopa) mm Hg
and for diastolic from 4 (debrisoquine) to 5 mm Hg (methyldopa,
propranolol), with no significant difference appearing between
active drugs. Propranolol was slightly better tolerated than the
others. After the study period, antihypertensive therapy at the
choice of the internist was continued in 36 patients. In these pa-
tients, with free choice of medication the drop in blood pressure
averaged 10/9 mm Hg. Conclusions. In the hands of practicing
internists, the antihypertensive efficacy of debrisoquine, methyl-
dopa, and propranolol is essentially equal. However, at the
doses used they were only slightly more effective than placebo.
Not surprisingly, internists in practice are able to obtain better
antihypertensive results when allowed free choice of medication.
Chloride reabsorption in various conditions of hypokalemia in
man. G. Williams, L. Favre, G. Lucot, H. Favre, andM. B. Val-
lotton. Divisions d'Endocrinologie et de Néphrologie, Hôpital
Cantonal, Genève, Switzerland. Because a defect in chloride
transport has been proposed as a specific cause of Bartter's syn-
drome, the relationship between fractional distal delivery of
chloride (FDD1) and fractional reabsorption of chloride (FDR1)
was studied in 8 patients with potassium depletion, by using
clearance techniques under maximal water diuresis. Two pa-
tients had all the characteristics of Bartter's syndrome; despite
chronic treatment with indomethacin, hypokalemia was still
present (plasma K, 2.2 and 2.3 mmoles/liter). Among the 6 other
K-depleted patients (plasma K, 1.7 to 3.4 mmoles/liter), there
were 2 cases of psychogenic vomiting, 2 laxative abusers, 1 case
of anorexia nervosa, and 1 experimental subject given a low-K
diet and cation exchange resin. For the 6 latter patients, FDR1
was positively correlated with inulin clearance (r = 0.63, P <
0.05), and inversely correlated with FDD1 (r = —0.94, P <
0.001), but completely unrelated to plasma K. In the 2 patients
with Bartter's syndrome, FDR1 was slightly lower than ex-
pected from the latter regression (0.63 and 0.72, c.f. predicted
0.85 and 0.87). However, these 2 values were similar to those
observed in 2 other hypokalemic patients having decreased in-
ulin clearance and increased FDD1 without Bartter's syndrome.
As the 2 cases of Bartter's syndrome had normal inulin clear-
ance, the effect of low GFR on FDR could not be evaluated in
this syndrome. After withdrawing indomethacin in one of the 2
cases, FDRCI remained unchanged, suggesting that prostaglan-
dins do not affect chloride reabsorption. Thus, a reduced FDR1
may well be a feature of Bartter's syndrome, but may also be
found in various conditions of potassium depletion associated
with renal failure, and consequently it cannot be used as a specif-
ic diagnostic criterium.
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Ticrynafen (tienilic acid), a uricosuric diuretic drug. G. G.
Geyskes, B. B. A. Laemers, J. J. M. van Bussel, P. Boer, and F.
J. Dorhout Mees. Department of Nephrology and Hypertension,
University Hospital, Utrecht, The Netherlands. In 24 patients
with essential hypertension (as defined by the World Health Or-
ganization as stages I and II) whose blood pressure remained>
130/90 during chronic atenolol treatment, the effects of adding
250 mg of ticrynafen (TCN) or 50 mg of chlortalidone (CHT)
were investigated in a double-blind crossover study. Serum uric
acid decreased during TCN and increased during CHT; CHT al-
so increased serum cholesterol concentration. As compared to
CHT, TCN caused less blood pressure reduction and less vol-
ume depletion (as measured by body weight and plasma renin
activity).
When CHT was replaced by TCN, the average urinary creati-
nine excretion of all patients was significantly lower on the first
day of TCN following CHT as compared to the preceding day on
CHT, but not on the first day TCN after placebo. One patient
complained of loin tenderness and showed diminished urine pro-
duction on the first day TCN directly following CHT in the pre-
ceding period. Blood studies revealed a renal insufficiency that
improved gradually after discontinuation of TCN. To study the
effect of replacing chronic CHT by TCN in more detail, we per-
formed a study in five hospitalized patients, also with essential
